These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 37798627
1. The most effective systemic treatment in dogs with sarcoptic mange: a critically appraised topic. Dumitrache MO, Cadiergues MC. BMC Vet Res; 2023 Oct 05; 19(1):189. PubMed ID: 37798627 [Abstract] [Full Text] [Related]
2. Efficacy of a chewable tablet containing sarolaner, moxidectin, and pyrantel (Simparica Trio®) in the treatment of sarcoptic mange caused by Sarcoptes scabiei mite infestations in dogs. Becskei C, Liebenberg J, Fernandes T, Borowski S, D'Hanis L, Mahabir SP. Parasit Vectors; 2023 Nov 27; 16(1):441. PubMed ID: 38012719 [Abstract] [Full Text] [Related]
3. Efficacy of orally and topically administered fluralaner (Bravecto®) for treatment of client-owned dogs with sarcoptic mange under field conditions. Chiummo R, Petersen I, Plehn C, Zschiesche E, Roepke R, Thomas E. Parasit Vectors; 2020 Oct 17; 13(1):524. PubMed ID: 33069261 [Abstract] [Full Text] [Related]
4. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs. Taenzler J, Liebenberg J, Roepke RK, Frénais R, Heckeroth AR. Parasit Vectors; 2016 Jul 07; 9(1):392. PubMed ID: 27387742 [Abstract] [Full Text] [Related]
5. Treatment of canine sarcoptic mange with afoxolaner (NexGard®) and afoxolaner plus milbemycin oxime (NexGard Spectra®) chewable tablets: efficacy under field conditions in Portugal and Germany. Hampel V, Knaus M, Schäfer J, Beugnet F, Rehbein S. Parasite; 2018 Jul 07; 25():63. PubMed ID: 30516132 [Abstract] [Full Text] [Related]
6. Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei. Beugnet F, de Vos C, Liebenberg J, Halos L, Larsen D, Fourie J. Parasite; 2016 Jul 07; 23():26. PubMed ID: 27317462 [Abstract] [Full Text] [Related]
7. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs. Becskei C, De Bock F, Illambas J, Cherni JA, Fourie JJ, Lane M, Mahabir SP, Six RH. Vet Parasitol; 2016 May 30; 222():56-61. PubMed ID: 26928658 [Abstract] [Full Text] [Related]
8. Efficacy of afoxolaner plus milbemycin oxime and afoxolaner alone as treatment for sarcoptic mange in naturally infested dogs. Romero-Núñez C, Bautista-Gómez LG, Sheinberg G, Martín-Cordero A, Flores-Ortega A, Heredia-Cárdenas R. Can J Vet Res; 2020 Jul 30; 84(3):212-216. PubMed ID: 32801456 [Abstract] [Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife. Takano K, de Hayr L, Carver S, Harvey RJ, Mounsey KE. Int J Parasitol Drugs Drug Resist; 2023 Apr 30; 21():97-113. PubMed ID: 36906936 [Abstract] [Full Text] [Related]
10. Assessment of the cytokine profile in peripheral blood mononuclear cells of naturally Sarcoptes scabiei var. canis infested dogs. Singh SK, Dimri U, Sharma B, Saxena M, Kumari P. Vet Parasitol; 2014 Dec 15; 206(3-4):253-7. PubMed ID: 25468023 [Abstract] [Full Text] [Related]
11. Efficacy of fluralaner in 17 dogs with sarcoptic mange. Romero C, Heredia R, Pineda J, Serrano JA, Mendoza GD, Trápala P, Cordero AM. Vet Dermatol; 2016 Oct 15; 27(5):353-e88. PubMed ID: 27511592 [Abstract] [Full Text] [Related]
12. Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use. Wilkinson V, Takano K, Nichols D, Martin A, Holme R, Phalen D, Mounsey K, Charleston M, Kreiss A, Pye R, Browne E, Næsborg-Nielsen C, Richards SA, Carver S. Parasit Vectors; 2021 Jan 06; 14(1):18. PubMed ID: 33407820 [Abstract] [Full Text] [Related]
13. Clinical efficacy of orally administered fluralaner for treatment of scabies in six free-ranging raccoon dogs (Nyctereutes procyonoides). Hyun JE, Jang HK, Hwang CY, Yeon SC. Vet Dermatol; 2019 Jun 06; 30(3):267-e81. PubMed ID: 30895701 [Abstract] [Full Text] [Related]
14. The efficacy of an imidacloprid/moxidectin combination against naturally acquired Sarcoptes scabiei infestations on dogs. Fourie LJ, Heine J, Horak IG. Aust Vet J; 2006 Jun 06; 84(1-2):17-21. PubMed ID: 16498829 [Abstract] [Full Text] [Related]
15. Efficacy of Fluralaner in the Treatment of Sarcoptic Mange (Sarcoptes scabiei) in 12 Pet Rabbits. d'Ovidio D, Santoro D. Top Companion Anim Med; 2021 Jun 06; 43():100528. PubMed ID: 33548547 [Abstract] [Full Text] [Related]
16. A retrospective investigation into risk factors of sarcoptic mange in dogs. Feather L, Gough K, Flynn RJ, Elsheikha HM. Parasitol Res; 2010 Jul 06; 107(2):279-83. PubMed ID: 20405144 [Abstract] [Full Text] [Related]
17. Therapeutic effects of oral fluralaner in pet rabbits with severe sarcoptic mange (Sarcoptes scabiei). Singh SK, Jaiswal AK, Kumari S, Gaur RS, Sharma P, Khushboo R, Jaiswal M. Vet Parasitol; 2022 Apr 06; 304():109693. PubMed ID: 35276384 [Abstract] [Full Text] [Related]
18. Effective treatment of sarcoptic mange in an alpaca (Vicugna pacos) using fluralaner: a case report. Sala G, Gazzonis AL, Pravettoni D, Cafiso A, Grilli G, Ferrulli V, Boccardo A, Di Cesare F, Pavesi LF, Zanzani S. Vet Res Commun; 2024 Jun 06; 48(3):1837-1843. PubMed ID: 38280082 [Abstract] [Full Text] [Related]
19. Sarcoptes scabiei var. canis refractory to ivermectin treatment in two dogs. Terada Y, Murayama N, Ikemura H, Morita T, Nagata M. Vet Dermatol; 2010 Dec 06; 21(6):608-12. PubMed ID: 20880016 [Abstract] [Full Text] [Related]
20. Are humans the initial source of canine mange? Andriantsoanirina V, Fang F, Ariey F, Izri A, Foulet F, Botterel F, Bernigaud C, Chosidow O, Huang W, Guillot J, Durand R. Parasit Vectors; 2016 Mar 25; 9():177. PubMed ID: 27015813 [Abstract] [Full Text] [Related] Page: [Next] [New Search]